Search

Somaly Sith Phones & Addresses

  • North Hollywood, CA
  • Stone Mountain, GA
  • Los Angeles, CA
  • 655 Mead St SE UNIT 15, Atlanta, GA 30312 (404) 954-1297
  • 1620 Hollywood Rd, Atlanta, GA 30318
  • Fairhope, AL
  • Decatur, GA
  • Kennesaw, GA

Publications

Us Patents

Micronized Placental Tissue Compositions And Methods Of Making And Using The Same

View page
US Patent:
20140050788, Feb 20, 2014
Filed:
Aug 9, 2013
Appl. No.:
13/963984
Inventors:
Randall Spencer - Marietta GA, US
Somaly Sith - Marietta GA, US
Assignee:
MiMedx Group Inc. - Marietta GA
International Classification:
A61K 35/50
A61K 45/06
A61K 9/14
US Classification:
424489, 424572
Abstract:
Described herein are compositions composed of micronized placental components, extracts of micronized placental components, and pharmaceutical compositions thereof. The compositions have numerous medical applications. Methods for making and using the micronized compositions and the extracts thereof are also described herein.

Placental Tissue Grafts Modified With A Cross-Linking Agent And Methods Of Making And Using The Same

View page
US Patent:
20140052247, Feb 20, 2014
Filed:
Mar 15, 2013
Appl. No.:
13/815747
Inventors:
Randall Spencer - Kennesaw GA, US
Brenda Morse - Kennesaw GA, US
Thomas J. Koob - Kennesaw GA, US
Somaly Sith - Kennesaw GA, US
Assignee:
MiMedx Group, Inc. - Kennesaw GA
International Classification:
A61L 27/50
US Classification:
623 1311, 623 2372
Abstract:
Described herein are tissue grafts derived from the placenta that possess good adhesion to biological tissues and are useful in would healing applications. In one aspect, the tissue graft includes (1) two or more layers of amnion, wherein at least one layer of amnion is cross-linked, (2) two or more layers of chorion, wherein at least one layer of chorion is cross-linked, or (3) one or more layers of amnion and chorion, wherein at least one layer of amnion and/or chorion is cross-linked. In another aspect, the grafts are composed of amnion and chorion cross-linked with one another. In a further aspect, the grafts have one or more layers sandwiched between the amnion and chorion membranes. The amnion and/or the chorion are treated with a cross-linking agent prior to the formation of the graft. The presence of the cross-linking agent present on the graft also enhances adhesion to the biological tissue of interest. Also described herein are methods for making and using the tissue grafts.

Micronized Placental Tissue Compositions And Methods Of Making And Using The Same

View page
US Patent:
20130344162, Dec 26, 2013
Filed:
Mar 6, 2013
Appl. No.:
13/787612
Inventors:
Brenda S. MORSE - Chamblee GA, US
Somaly SITH - Stone Mountain GA, US
Randall SPENCER - Kennesaw GA, US
Steven RAY - Kingston GA, US
John DANIEL - Kennesaw GA, US
Robert Tofe - Denver CO, US
International Classification:
A61K 35/50
US Classification:
424582
Abstract:
Described herein are composition composed of micronized placental components and pharmaceutical compositions thereof. The compositions have numerous medical applications. Methods for making and using the micronized compositions are also described herein.

Micronized Placental Tissue Compositions And Methods Of Making And Using The Same

View page
US Patent:
20190374584, Dec 12, 2019
Filed:
Jul 24, 2019
Appl. No.:
16/520909
Inventors:
- Marietta GA, US
Somaly Sith - Stone Mountain GA, US
Randall Spencer - Kennesaw GA, US
Steven Ray - Kingston GA, US
John Daniel - Kennesaw GA, US
Robert Tofe - Denver CO, US
International Classification:
A61K 35/50
A61K 35/12
A61P 17/02
A61K 8/98
A61Q 19/00
A61L 27/36
Abstract:
Described herein are composition composed of micronized placental components and pharmaceutical compositions thereof. The compositions have numerous medical applications. Methods for making and using the micronized compositions are also described herein.

Micronized Wharton's Jelly

View page
US Patent:
20190307812, Oct 10, 2019
Filed:
Apr 18, 2019
Appl. No.:
16/388334
Inventors:
- Marietta GA, US
Somaly Sith - Marietta GA, US
Tom Koob - Marietta GA, US
Assignee:
MiMedx Group, Inc. - Marietta GA
International Classification:
A61K 35/51
A61K 9/00
C12N 5/078
A61K 9/16
A61K 9/14
Abstract:
The present invention provides compositions and formulations of micronized Wharton's jelly having a controlled viscosity such that when delivered to the injured region of a subject, it remains substantially localized with little or no migration out of the injured region for the repair and/or regeneration thereof. Micronized Wharton's Jelly can be suspended in a pharmaceutically acceptable aqueous carrier, such as saline, sterile water, or any suitable buffer, to form a suspension or a gelatinous gel composition, or it can be in the form of a paste, suitable for delivery into the space adjacent the articular surface cartilage injured region of a subject. The micronized Wharton's jelly when employed at sufficient concentrations can be hydrated into a gel or paste and administered topically, or it can be injected into the body through the use of a needle and syringe. Accordingly, micronized Wharton's Jelly, compositions, or formulations thereof, can be delivered in a manner that is more convenient than Wharton's jelly that has not been micronized in accordance with the present invention.

Laminated Tissue Grafts Composed Of Wharton's Jelly And Methods Of Making And Using The Same

View page
US Patent:
20190307921, Oct 10, 2019
Filed:
May 23, 2019
Appl. No.:
16/421086
Inventors:
- Marietta GA, US
Somaly Sith - Marietta GA, US
Randall Spencer - Marietta GA, US
John Daniel - Marietta GA, US
Robert Tofe - Marietta GA, US
Assignee:
MiMedx Gruop, Inc. - Marietta GA
International Classification:
A61L 27/36
A61L 27/50
A61K 35/50
Abstract:
Described herein are tissue grafts derived from the placenta with improved physical and biological properties. In one aspect, the tissue graft includes a first membrane comprising Wharton's jelly laminated with amnion, chorion, or a combination thereof. The presence of Wharton's jelly in the grafts enhances the performance of allograft amniotic-derived, caderivic allograft, xenograft, or alloplast soft tissue substitutes.

Tissue Grafts Modified With A Cross-Linking Agent And Method Of Making And Using The Same

View page
US Patent:
20190192736, Jun 27, 2019
Filed:
Jan 29, 2019
Appl. No.:
16/260733
Inventors:
- Marietta GA, US
Somaly Sith - Marietta GA, US
Randall Spencer - Marietta GA, US
John Daniel - Marietta GA, US
Assignee:
MiMedx Group, Inc. - Marietta GA
International Classification:
A61L 27/38
A61L 27/36
A61K 35/50
Abstract:
Described herein are tissue grafts derived from the placenta that possess good adhesion to biological tissues and are useful in would healing applications. In one aspect, the tissue graft includes (1) two or more layers of amnion, wherein at least one layer of amnion is cross-linked, (2) two or more layers of chorion, wherein at least one layer of amnion is cross-linked, or (3) one or more layers of amnion and chorion, wherein at least one layer of amnion and/or chorion is cross-linked. In another aspect, the grafts are composed of amnion and chorion cross-linked with one another. In a further aspect, the grafts have one or more layers sandwiched between the amnion and chorion membranes. The amnion and/or the chorion are treated with a cross-linking agent prior to the formation of the graft. The presence of the cross-linking agent present on the graft also enhances adhesion to the biological tissue of interest. Also described herein are methods for making and using the tissue grafts.

Tissue Grafts Modified With A Cross-Linking Agent And Method Of Making And Using The Same

View page
US Patent:
20190175789, Jun 13, 2019
Filed:
Jan 29, 2019
Appl. No.:
16/260738
Inventors:
- Marietta GA, US
Somaly Sith - Marietta GA, US
Randall Spencer - Marietta GA, US
John Daniel - Marietta GA, US
Assignee:
MiMedx Group, lnc. - Marietta GA
International Classification:
A61L 27/38
A61L 27/36
A61K 35/50
Abstract:
Described herein are tissue grafts derived from the placenta that possess good adhesion to biological tissues and are useful in would healing applications. In one aspect, the tissue graft includes (1) two or more layers of amnion, wherein at least one layer of amnion is cross-linked, (2) two or more layers of chorion, wherein at least one layer of amnion is cross-linked, or (3) one or more layers of amnion and chorion, wherein at least one layer of amnion and/or chorion is cross-linked. In another aspect, the grafts are composed of amnion and chorion cross-linked with one another. In a further aspect, the grafts have one or more layers sandwiched between the amnion and chorion membranes. The amnion and/or the chorion are treated with a cross-linking agent prior to the formation of the graft. The presence of the cross-linking agent present on the graft also enhances adhesion to the biological tissue of interest. Also described herein are methods for making and using the tissue grafts.
Somaly Sith from North Hollywood, CA, age ~37 Get Report